Discovery of a novel dual EGFR/HER-2 inhibitor

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 06期
关键词：
RESISTANCE; GEFITINIB;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：745 / 745
页数：1
相关论文
共 50 条
  • [1] Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer
    Zhang, Long
    Fan, Chuanwen
    Guo, Zongru
    Li, Ying
    Zhao, Shuyong
    Yang, Shaobo
    Yang, Yingying
    Zhu, Jianrong
    Lin, Dong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 : 833 - 841
  • [2] Afatinib, an EGFR/Her-2 dual inhibitor, effectively radiosensitizes bladder cancer cells
    Tsai, Yu-Chieh
    Chen, Jason Chia-Hsien
    Tuan, Tsung-Fan
    Yeh, Chih-Hsien
    Ho, Pei-Yin
    Pu, Yeong-Shiau
    Cheng, Ann-Lii
    CANCER RESEARCH, 2012, 72
  • [3] Dual HER-2/EGFR tyrosine kinase inhibitors
    Cardoso F.
    Breast Cancer Research, 3 (1)
  • [4] Synthesis and evaluation of novel pyrimidine-based dual EGFR/Her-2 inhibitors
    Suzuki, Naoyuki
    Shiota, Takeshi
    Watanabe, Fumihiko
    Haga, Norihiro
    Murashi, Takami
    Ohara, Takafumi
    Matsuo, Kenji
    Oomori, Naoki
    Yari, Hiroshi
    Dohi, Keiji
    Inoue, Makiko
    Iguchi, Motofumi
    Sentou, Jyunko
    Wada, Tooru
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1601 - 1606
  • [5] Synthesis and evaluation of novel pyrimidine-based dual EGFR/Her-2 inhibitors
    Suzuki, Naoyuki
    Shiota, Takeshi
    Watanabe, Fumihiko
    Haga, Norihiro
    Murashi, Takami
    Ohara, Takafumi
    Matsuo, Kenji
    Omori, Naoki
    Hiroshi, Yari
    Dohi, Keiji
    Inoue, Makiko
    Iguchi, Motofumi
    Sento, Jyunko
    Wada, Tooru
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [6] Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases
    Suzuki, Naoyuki
    Shiota, Takeshi
    Watanabe, Fumihiko
    Haga, Norihiro
    Murashi, Takami
    Ohara, Takafumi
    Matsuo, Kenji
    Omori, Naoki
    Yari, Hiroshi
    Dohi, Keiji
    Inoue, Makiko
    Iguchi, Motofumi
    Sentou, Jyunko
    Wada, Tooru
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 456 - 460
  • [7] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Efstathia Giannopoulou
    Anna Antonacopoulou
    Konstantina Floratou
    Athanasios G. Papavassiliou
    Haralabos P. Kalofonos
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 973 - 981
  • [8] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Giannopoulou, Efstathia
    Antonacopoulou, Anna
    Floratou, Konstantina
    Papavassiliou, Athanasios G.
    Kalofonos, Haralabos P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 973 - 981
  • [9] Dual targeting of EGFR and HER-2 in colon cancer cell lines
    Giannopoulou, E.
    Antonacopoulou, A.
    Floratou, K.
    Kalofonos, H.
    FEBS JOURNAL, 2008, 275 : 306 - 306
  • [10] Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
    Roque Diaz
    Paul A Nguewa
    Ricardo Parrondo
    Carlos Perez-Stable
    Irene Manrique
    Miriam Redrado
    Raul Catena
    Maria Collantes
    Ivan Peñuelas
    Juan Antonio Díaz-González
    Alfonso Calvo
    BMC Cancer, 10
12345